Exclusive-Polish drug maker Polpharma working on bid for Advent’s Zentiva – sources

Published by
Reuters UK

By Pamela Barbaglia LONDON (Reuters) – Poland’s largest drug maker Polpharma is working on a possible $4 billion takeover of Czech rival Zentiva and is looking for investors to join its bid in return for a minority stake in the Advent International company, three sources said. Discussions between Polpharma and potential partners are at an early stage and the Polish company has yet decide how it would structure a joint bidding vehicle, the sources said on condition of anonymity, warning that no deal was certain. Polpharma’s move comes after Advent snubbed proposals from banks last year for an i…

Read More